BG Medicine, Inc.
BGMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.14K
Close$
Share Statistics
| Market cap | $1,137.00 |
|---|---|
| Enterprise Value | $-1,273,863.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 0.37 |
| Outstanding Shares | 11,263,752 |
Return
| Return on Equity | 268.32% |
|---|---|
| Return on Assets | -248.57% |
| Return on Invested Capital | -539.66% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | -0.81 |
| Enterprise Value to EBIT | 0.25 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.2 |
| Debt to Equity | -0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BG Medicine, Inc.
5 employees
CEO: Stephen Hall BG Medicine, Inc. is dedicated to the development and commercialization of diagnostic products aimed at guiding patient care for individuals in the United States afflicted with heart failure and related conditions. Its product portfolio ...